Frontlight ResearchEarly access
Trial site
Long Beach Research Institute
- 9running trials
- 4closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Atopic dermatitis (eczema)3 trials
- Diabetic neuropathy3 trials
- Psoriasis3 trials
- Type 2 diabetes3 trials
- Coronary artery disease2 trials
- Chronic kidney disease1 trial
- Heart failure1 trial
- Narcolepsy1 trial
- Obesity1 trial
- Peripheral artery disease1 trial
- Stroke1 trial
- Phase
- Phase 312 trials
- Status
- Active, not recruiting5 trials
- Completed4 trials
- Recruiting4 trials
- Lead sponsor
- Amgen3 trials
- Vertex Pharmaceuticals Incorporated3 trials
- Alumis Inc2 trials
- Eli Lilly and Company2 trials
- Cleerly, Inc.1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
Active, not recruiting
Recruiting
Active, not recruiting
A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Diabetic neuropathy2 recruiting
- Coronary artery disease1 recruiting
- Narcolepsy1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Completed
Completed
Completed
A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)
Site data: ClinicalTrials.govUpdated 15 Nov 2026